142 pending office actions • 81 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19107055 | GADUSOL-CONTAINING SUNSCREEN FORMULATIONS | Arcaea, LLC | TCHERKASSKAYA, OLGA V | 1615 | Non-Final OA | Feb 27, 2025 |
| 18824616 | EQUANIMITY - DYNAMIC PHYSIOLOGY | Arizona Board of Regents | DIETRICH, JOSEPH M | 3796 | Non-Final OA | Sep 04, 2024 |
| 18833322 | RADIOSENSITIZING COMPOSITIONS AND METHODS OF USE THEREOF | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | PIPIC, ALMA | 1617 | Non-Final OA | Jul 25, 2024 |
| 18772004 | MUNITIONS AND ORDNANCE REMEDIATION BLANKET (MORB) AND METHODS OF USING SAME | MuniRem Environmental, LLC | HAYES, BRET C | 3641 | Non-Final OA | Jul 12, 2024 |
| 18678738 | EFFECTIVE EYELID, FACE, HEAD AND BODY CLEANSER | Unknown | MOREAU, NASHARA LOUISE | 1655 | Non-Final OA | May 30, 2024 |
| 18674209 | POLY(AMINE-CO-ESTER) POLYMERS AND POLYPLEXES WITH MODIFIED END GROUPS AND METHODS OF USE THEREOF | Yale University | COHEN, MICHAEL P | 1612 | Non-Final OA | May 24, 2024 |
| 18653590 | OCULAR ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF | The University of Hong Kong | IANNUZO, NATALIE NMN | 1653 | Non-Final OA | May 02, 2024 |
| 18653312 | COMPOSITIONS AND METHODS FOR TARGETING CD99-EXPRESSING CANCERS | H. Lee Moffitt Cancer Center and Research Institute, Inc. | XIE, XIAOZHEN | 1674 | Non-Final OA | May 02, 2024 |
| 18652429 | TUMOR ASSOCIATED MONOCYTE/MACROPHAGE BINDING PEPTIDE AND METHODS OF USE THEREOF | Sanford Burnham Prebys Medical Discovery Institute | HA, JULIE | 1654 | Non-Final OA | May 01, 2024 |
| 18703686 | METHODS FOR MAKING EXTRACELLULAR VESICLES, AND COMPOSITIONS AND METHODS OF USE THEREOF | Evia Life Sciences Inc. | AMIN, ALPA NILESH | 1655 | Non-Final OA | Apr 22, 2024 |
| 18701567 | DELIVERY OF THERAPEUTIC RECOMBINANT URICASE USING NANOPARTICLES | Georgia Tech Research Corporation | BOWERS, ERIN M | 1653 | Non-Final OA | Apr 15, 2024 |
| 18622465 | CARBON NANOTUBE-BASED THERMAL INTERFACE MATERIALS AND METHODS OF MAKING AND USING THEREOF | Carbice Corporation | ROJOHN III, CLAIRE E | 3763 | Non-Final OA | Mar 29, 2024 |
| 18692729 | NANOPARTICLE SURFACE TOPOGRAPHY MODIFIED WITH BOTTLEBRUSH BLOCK COPOLYMERS | Yale University | ABBAS, ABDULRAHMAN MUSTAFA | 1612 | Non-Final OA | Mar 15, 2024 |
| 18605474 | COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASE | Ramot AT Tel-Aviv University Ltd. | NEAGU, IRINA | 1629 | Non-Final OA | Mar 14, 2024 |
| 18690140 | PHARMACEUTICAL COMPOSITION COMPRISING LARGE PHYSIOLOGICALLY ACTIVE SUBSTANCE AND EXCIPIENT | D&D Pharmatech Inc. | MAEWALL, SNIGDHA | 1612 | Non-Final OA | Mar 07, 2024 |
| 18688300 | GLUN2B-SUBUNIT SELECTIVE ANTAGONISTS OF THE N-METHYL-D-ASPARTATE RECEPTORS WITH ENHANCED POTENCY AT ACIDIC PH | Neurop, Inc. | SHTERENGARTS, SAMANTHA L | 1623 | Non-Final OA | Feb 29, 2024 |
| 18681561 | FIBRINOGEN COMPOSITIONS AND METHODS OF PREPARATION | Biotest AG | GOTFREDSON, GAREN | 1619 | Non-Final OA | Feb 06, 2024 |
| 18577631 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | BELL, SARA ELIZABETH | 1625 | Non-Final OA | Jan 08, 2024 |
| 18542277 | DNA METHYLATION BIOMARKERS FOR CANCER DIAGNOSING | Arizona Board of Regents | GOLDBERG, JEANINE ANNE | 1682 | Final Rejection | Dec 15, 2023 |
| 18569361 | ROS-RESPONSIVE CAPTOPRIL-CINNAMALDEHYDE PRODRUGS AND COMPOSITIONS AND METHODS THEREOF | The University of Hong Kong | CHANDRAKUMAR, NIZAL S | 1625 | Non-Final OA | Dec 12, 2023 |
| 18564498 | BIOENGINEERED DERMAL PAPILLA AND HAIR FOLLICLES AND RELATED PRODUCTS, METHODS AND APPLICATIONS | The University of Hong Kong | MATALKAH, FATIMAH KHALAF | 1638 | Non-Final OA | Nov 27, 2023 |
| 18563314 | DINUCLEAR PLATINUM EMITTER COMPLEXES AND METHODS OF MAKING AND USING THEREOF | Hong Kong Quantum AI Lab Limited | DULKA, JOHN P | 2817 | Non-Final OA | Nov 21, 2023 |
| 18506847 | BICYCLIC HETEROCYCLIC COMPOUNDS FOR PROPHYLAXIS AND TREATMENT OF VIRAL INFECTIONS | BM Pharma Consulting Pty Ltd. | BURKETT, DANIEL JOHN | 1624 | Non-Final OA | Nov 10, 2023 |
| 18503100 | COMPOSITIONS AND METHODS FOR MAKING PARASYMPATHETIC NEURONS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | JACKSON III, WALTER | 1638 | Non-Final OA | Nov 06, 2023 |
| 18558943 | SEQUENCE-DEFINED POLYMERS WITH ONE OR MORE AZIDES, METHODS OF MAKING, AND METHODS OF USE THEREOF | Yale University | SPANGLER, JOSEPH RANKIN | 1656 | Non-Final OA | Nov 03, 2023 |
| 18500774 | ENGINEERED EXOSOMES TO DETECT AND DEPLETE PRO-TUMORIGENIC MACROPHAGES | Augusta University Research Institute, Inc. | NICOL, ALEXANDER W | 1634 | Non-Final OA | Nov 02, 2023 |
| 18383131 | Filter and Frame Apparatus and Method of Use | Delcath Systems, Inc. | KURTZ, BENJAMIN M | 1779 | Non-Final OA | Oct 24, 2023 |
| 18490443 | USE OF A SPLIT dCAS FUSION PROTEIN SYSTEM FOR EPIGENETIC EDITING | The Regents of the University of California | PHILIPOSE, HANNAH SARAH | 1631 | Non-Final OA | Oct 19, 2023 |
| 18375697 | COMPOSITIONS AND METHODS FOR TREATING OCULAR CHEMICAL BURNS | Ohio State Innovation Foundation | COUGHLIN, MATTHEW P | 1626 | Non-Final OA | Oct 02, 2023 |
| 18478247 | ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T REGULATORY CELLS | H. Lee Moffitt Cancer Center and Research Institute, Inc. | BELYAVSKYI, MICHAIL A | 1644 | Final Rejection | Sep 29, 2023 |
| 18473956 | COMPOSITIONS FOR CORONAVIRUS DETECTION AND METHODS OF MAKING AND USING THEROF | The Hospital Authority | WANG, RUIXUE | 1672 | Non-Final OA | Sep 25, 2023 |
| 18549950 | CHIPS AND METHODS | Imperial College Innovations Ltd. | KIDWELL, KAITLYN ELIZABETH | 2877 | Final Rejection | Sep 11, 2023 |
| 18464817 | Dental Care Products Comprising Stannous Flouride | Credentis AG | JAUHARI, SACHI | 1654 | Non-Final OA | Sep 11, 2023 |
| 18549770 | METHODS, SYSTEMS, AND DEVICES FOR GENERATING DEFINED FIBER CONSTRUCTS | Arizona Board of Regents | LEYSON, JOSEPH S | 1744 | Non-Final OA | Sep 08, 2023 |
| 18547748 | METHODS FOR TREATING CD83-EXPRESSING CANCER | Regents Of The University Of Minnesota | GODDARD, LAURA B | 1642 | Non-Final OA | Aug 24, 2023 |
| 18453159 | COMPOSITIONS, IMAGING, AND THERAPEUTIC METHODS TARGETING FOLATE RECEPTOR 1 (FOLR1) | Indi Molecular, Inc. | OLISS, BRENDAN PATRICK NOON | 1658 | Non-Final OA | Aug 21, 2023 |
| 18546895 | ANTI-VIRAL PEPTIDES AND COMPOSITIONS AND METHODS OF USE THEREOF | Centre For Virology, Vaccinology And Therapeutics Limited | KOMATSU, LI N | 1658 | Non-Final OA | Aug 17, 2023 |
| 18546733 | ANTIBACTERIAL AND MINERALIZING COMPOSITIONS AND METHODS OF USE THEREOF | The University of Hong Kong | WEBB, WALTER E | 1612 | Non-Final OA | Aug 16, 2023 |
| 18450181 | METHODS FOR PRODUCTION OF FUCOSYLATED OLIGOSACCHARIDES IN RECOMBINANT CELL CULTURE | The Regents of the University of California | MONSHIPOURI, MARYAM | 1651 | Non-Final OA | Aug 15, 2023 |
| 18546408 | DOUBLE-SHELL NEODYMIUM-IRON-BORON MAGNET AND PREPARATION METHOD THEREFOR | Fujian Golden Dragon Rare-Earth Co., Ltd. | WU, JENNY R | 1733 | Non-Final OA | Aug 14, 2023 |
| 18546302 | CUSTOMIZED CHIMERIC ANTIGEN RECEPTOR POLYPEPTIDES | H. Lee Moffitt Cancer Center and Research Institute, Inc. | GUSTILO, ESTELLA M | 1646 | Non-Final OA | Aug 14, 2023 |
| 18264695 | CELL NICHE ENGINEERING PLATFORM, MULTIPLEXED BIOCHIPS RESULTING THEREFROM AND METHODS OF USE THEREOF | The University of Hong Kong | HASSAN, LIBAN M | 1799 | Non-Final OA | Aug 08, 2023 |
| 18356886 | EXTRACELLULAR VESICLE PROTEOMIC BIOMARKER PANEL FOR OVARIAN CANCER SCREENING AND THE EARLY DETECTION OF DISEASE | UNIVERSITY OF KANSAS | BELLAH, JEFFREY LAWRENCE | 1683 | Non-Final OA | Jul 21, 2023 |
| 18357065 | COMPOSITIONS AND METHODS FOR DETECTING TRYPANOSOMA CRUZI INFECTION | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | CHEONG, CHEOM-GIL | 1645 | Non-Final OA | Jul 21, 2023 |
| 18262287 | BI-SPECIFIC CAR T CCELLS FOR B CELL MALIGNANCIES | H. Lee Moffitt Cancer Center and Research Institute, Inc. | METCALF, MATTHEW CURRAN | 1647 | Non-Final OA | Jul 20, 2023 |
| 18262174 | METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES | Augusta University Research Institute, Inc. | MILLER, DALE R | 1693 | Non-Final OA | Jul 19, 2023 |
| 18353717 | DINUCLEAR PLATINUM COMPLEXES FOR OLED APPLICATION | Hong Kong Quantum AI Lab Limited | DEKARSKE, MADELINE MCGUIRE | 1622 | Non-Final OA | Jul 17, 2023 |
| 18352040 | COMPOSITIONS AND METHODS TARGETING S100A10 FOR THE TREATMENT AND DIAGNOSIS OF LIVER CANCER | The University of Hong Kong | CASH, KAILEY ELIZABETH | 1683 | Non-Final OA | Jul 13, 2023 |
| 18350402 | COMPOSITIONS OF CASPASE INHIBITORS AND METHODS OF USE THEREOF | Centre For Virology, Vaccinology And Therapeutics Limited | OLISS, BRENDAN PATRICK NOON | 1658 | Non-Final OA | Jul 11, 2023 |
| 18347151 | CRYOGEL 3D SCAFFOLDS AND METHODS FOR PRODUCING THEREOF | ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) | MOLOYE, TITILAYO | 1632 | Non-Final OA | Jul 05, 2023 |
| 18269114 | A METHOD | ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE | WOLLSCHLAGER, JEFFREY MICHAEL | 1742 | Non-Final OA | Jun 22, 2023 |
| 18267931 | COMPOSITIONS IMMUNOGENIC AGAINST INFLUENZA AND SARS CORONAVIRUS 2, METHODS OF MAKING AND USING THEREOF | VERSITECH LIMITED | LI, BAO Q | 1671 | Non-Final OA | Jun 16, 2023 |
| 18335922 | COMPOSITIONS CONTAINING AMINO ACIDS AS AN ADMIXTURE FOR CEMENT-BASED MATERIALS | The University of Maine System Board of Trustees | GREEN, ANTHONY J | 1731 | Non-Final OA | Jun 15, 2023 |
| 18256037 | TARGETING OF NEUTROPHIL EXTRACELLULAR TRAPS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF | Netris Biomedical LLC | ALFANO, ALAN | 1641 | Non-Final OA | Jun 05, 2023 |
| 18039130 | BIOLOGICALLY ACTIVE MATERIAL CONJUGATE HAVING BIOTIN MOIETY, FATTY ACID MOIETY, OR COMBINATION THEREOF COUPLED THERETO | D&D Pharmatech Inc. | COFFA, SERGIO | 1658 | Non-Final OA | May 26, 2023 |
| 18254669 | LENTIVIRAL VECTOR TECHNOLOGY FOR INNER EAR GENE THERAPY | Medizinische Hochschule Hannover | YU, DELPHINUS DOU YI | 1636 | Non-Final OA | May 26, 2023 |
| 18039184 | ORAL FORMULATION OF BIOLOGICALLY ACTIVE MATERIAL CONJUGATE HAVING BIOTIN MOIETY, FATTY ACID MOIETY, OR COMBINATION THEREOF COUPLED THERETO | D&D Pharmatech Inc. | LIEB, JEANETTE M | 1654 | Non-Final OA | May 26, 2023 |
| 18253891 | COMPOSITIONS AND METHODS FOR BLOCKING NEUROPILIN RECEPTOR 1 FOR THE TREATMENT OF PAIN AND PREVENTION OF VIRAL ENTRY | Arizona Board of Regents | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | Non-Final OA | May 22, 2023 |
| 18036825 | METHODS AND COMPOSITIONS FOR CANCER THERAPY | Ohio State Innovation Foundation | FAY, ZOHREH ALEMZADEH | 1617 | Non-Final OA | May 12, 2023 |
| 18315906 | POXVIRUS ADJUVANT FOR T-CELL VACCINATION | Pellis Therapeutics, Inc. | LI, BAO Q | 1671 | Non-Final OA | May 11, 2023 |
| 18314688 | IMMUNOTHERAPY OF SKIN CANCER USING MPLA-LOADED HPG NANOPARTICLES | Yale University | RONEY, CELESTE A | 1612 | Final Rejection | May 09, 2023 |
| 18312492 | FORMULATIONS AND MEDICAL DEVICES FOR MINIMALLY-INVASIVE DEEP TISSUE APPLICATIONS | President and Fellows of Harvard College | WHITE, KIA XIONG | 3774 | Non-Final OA | May 04, 2023 |
| 18251374 | TRANSFERABLE TYPE I-F CRISPR-CAS GENOME EDITING SYSTEM | The University of Hong Kong | LIPPOLIS, ALEXANDRA ROSE | 1637 | Non-Final OA | May 01, 2023 |
| 18249926 | COMPOSITIONS OF ANTI-VIRAL PEPTIDES AND/OR COMPOUNDS AND METHODS OF USE THEREOF | The University of Hong Kong | KATAKAM, SUDHAKAR | 1658 | Non-Final OA | Apr 20, 2023 |
| 18249806 | METHOD AND KIT FOR TESTING IMMUNOMODULATORY POTENCY OF IMMUNOGLOBULIN COMPOSITIONS, e.g. FOR TREATMENT OF COVID 19 | Biotest AG | EVANS, CHRISTOPHER RYAN | 1677 | Non-Final OA | Apr 20, 2023 |
| 18248285 | METHODS AND MEANS FOR AMPLIFICATION-BASED QUANTIFICATION OF NUCLEIC ACIDS | Imperial College Innovations Limited | GIAMMONA, FRANCESCA FILIPPA | 1681 | Non-Final OA | Apr 07, 2023 |
| 18185164 | CXCL14 AS PREDICTIVE BIOMARKER FOR ACUTE LIVER FAILURE AND DEATH | UNIVERSITY OF KANSAS | HOFFMAN, ALEXANDER JOSEPH | 1677 | Non-Final OA | Mar 16, 2023 |
| 18245217 | COMPOSITIONS AND METHODS FOR INHIBITING TREM-1 | Augusta University Research Institute, Inc. | JOHNSON, CHRISTOPHER LINDSAY | 1691 | Non-Final OA | Mar 14, 2023 |
| 18179069 | ENTERAL CARBON MONOXIDE FOR THE PREVENTION AND TREATMENT OF OCULAR DISEASES | Hillhurst Biopharmaceuticals, Inc. | STEINKE, SEAN JAMES | 1619 | Final Rejection | Mar 06, 2023 |
| 18170997 | TARGETED DELIVERY OF DRUG MOLECULES WITH DRUG LIGANDS CONJUGATED TO RNA NANOPARTICLE MOTION ELEMENTS | Ohio State Innovation Foundation | PAULUS, ERIN VIRGINIA | 1631 | Non-Final OA | Feb 17, 2023 |
| 18169695 | HEMOSTATIC NANOPARTICLES FOR THE TREATMENT OF NON-COMPRESSIBLE HEMORRHAGE AND INTERNAL BLEEDING | The General Hospital Corporation | STEVENS, MARK V | 1613 | Non-Final OA | Feb 15, 2023 |
| 18007378 | COMPOSITION AND METHOD | Cambridge Enterprise Limited | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | Non-Final OA | Jan 30, 2023 |
| 18005016 | FORMATE-INDUCIBLE PROMOTERS AND METHODS OF USE THEREOF | Imperial College Innovations Ltd. | RYAN, DOUGLAS CHARLES | 1635 | Non-Final OA | Jan 10, 2023 |
| 18003922 | DUAL CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING CCD99- AND CLEC12A-EXPRESSING CANCERS | H. Lee Moffitt Cancer Center and Research Institute, Inc. | JUEDES, AMY E | 1644 | Non-Final OA | Dec 30, 2022 |
| 18012468 | A MECHANOMYOGRAPHY APPARATUS AND ASSOCIATED METHODS | Imperial College Innovations Limited | CERIONI, DANIEL LEE | 3791 | Final Rejection | Dec 22, 2022 |
| 18011635 | INTRAVESICAL DELIVERY OF HYDROPHILIC THERAPEUTIC AGENTS USING LIPOSOMES | Lipella Pharmaceuticals Inc. | SHOMER, ISAAC | 1612 | Final Rejection | Dec 20, 2022 |
| 18063604 | COMPOSITIONS AND METHODS FOR IMPROVED MESENCHYMAL STEM CELL THERAPY | The Chinese University of Hong Kong | WHITE, DAWANNA SHAR-DAY | 1627 | Final Rejection | Dec 08, 2022 |
| 18000491 | COMPOSITIONS AND METHODS FOR TREATING A SARS-COV-2 INFECTION | The University of Hong Kong | NGUYEN, NGOC-ANH THI | 1615 | Final Rejection | Dec 01, 2022 |
| 18000425 | SSTR-2 Binding Chimeric Antigen Receptors | UNIVERSITA' DEGLI STUDI DI BARI ALDO MORO | DARPOLOR, JOSEPHINE KEBBEH | 1642 | Final Rejection | Dec 01, 2022 |
| 18000312 | Dual EGFR-MUC1 Chimeric Antigen Receptor T Cells | H. Lee Moffitt Cancer Center and Research Institute, Inc. | HOPKINS, SAMANTHA LAKE | 1641 | Non-Final OA | Nov 30, 2022 |
| 18000075 | GENE FOR REGULATING BRANCH NUMBERS OF SOYBEAN AND USE THEREOF | Institute Of Genetics And Developmental Biology Chinese Academy Of Sciences | CHATTERJEE, JAYANTA | 1662 | Non-Final OA | Nov 28, 2022 |
| 18058169 | VIRAL NUCLEIC ACID MOLECULES, AND COMPOSITIONS AND METHODS OF USE THEREOF | Centre For Virology, Vaccinology And Therapeutics Limited | KINSEY WHITE, NICOLE ERIN | 1672 | Non-Final OA | Nov 22, 2022 |
| 18057632 | d10 METAL CARBENE COMPLEXES FOR OLED APPLICATIONS | Hong Kong Quantum AI Lab Limited | KERSHNER, DYLAN CLAY | 1786 | Non-Final OA | Nov 21, 2022 |
| 17998790 | CANNABIDIOL AS A THERAPEUTIC MODALITY FOR COVID-19 | Augusta University Research Institute, Inc. | RAMACHANDRAN, UMAMAHESWARI | 1627 | Final Rejection | Nov 14, 2022 |
| 17997434 | SARS-COV-2 VIRAL PROTEINS AND USE THEREOF | Institut Pasteur | CHEN, STACY BROWN | 1672 | Non-Final OA | Oct 28, 2022 |
| 17996427 | COMPOSITIONS AND METHODS FOR TREATING LEUKEMIA | Augusta University Research Institute, Inc. | SEITZ, ANTHONY JOSEPH | 1629 | Non-Final OA | Oct 17, 2022 |
| 18046619 | DIAGNOSIS AND TREATMENT OF CANCER | Rab Diagnostics AS | YAO, LEI | 1642 | Final Rejection | Oct 14, 2022 |
| 17918084 | METHODS AND COMPOSITION FOR TREATMENT OF COVID-19 ILLNESS REQUIRING HOSPITALIZATION | Ohio State Innovation Foundation | HAVLIN, ROBERT H | 1626 | Non-Final OA | Oct 10, 2022 |
| 17906279 | DESIGNER EXTRACELLULAR VESICLES FOR TREATING EXCITOTOXICITY | Ohio State Innovation Foundation | TICHY, JENNIFER M.H. | 1653 | Final Rejection | Sep 14, 2022 |
| 17930591 | COMPOSITIONS IMMUNOGENIC AGAINST SARS CORONAVIRUS 2, METHODS OF MAKING, AND USING THEREOF | VERSITECH LIMITED | HOLLAND, PAUL J | 1656 | Final Rejection | Sep 08, 2022 |
| 17905131 | TUMOR-INFILTRATING LYMPHOCYTES WITH ENHANCED TUMOR REACTIVITY | H. Lee Moffitt Cancer Center and Research Institute, Inc. | ABUZEINEH, HANAN ISAM | 1633 | Final Rejection | Aug 26, 2022 |
| 17821411 | COMPOSITIONS AND METHODS FOR DETECTING SARS-CoV-2 | The University of Hong Kong | BARRERA, IMMACULADA | 1671 | Final Rejection | Aug 22, 2022 |
| 17871412 | COSMECEUTICAL COMPOSITION | Ohio State Innovation Foundation | PRAGANI, RAJAN | 1614 | Final Rejection | Jul 22, 2022 |
| 17759271 | BI-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING CD83 AND INTERLEUKIN 6 RECEPTOR | H. Lee Moffitt Cancer Center and Research Institute, Inc. | WESTON, ALYSSA G | 1633 | Final Rejection | Jul 21, 2022 |
| 17868214 | BINUCLEAR GOLD(I) COMPOUNDS FOR PHOTOCATALYSIS APPLICATIONS | Laboratory For Synthetic Chemistry And Chemical Biology Limited | QIAN, YUN | 1738 | Non-Final OA | Jul 19, 2022 |
| 17756386 | CAR T CELLS WITH ENHANCED METABOLIC FITNESS | H. Lee Moffitt Cancer Center and Research Institute, Inc. | BERTOGLIO, VALARIE E | 1632 | Final Rejection | May 24, 2022 |
| 17756138 | AKT INHIBITORS FOR ENHANCING CHIMERIC T CELL PERSISTENCE | H. Lee Moffitt Cancer Center and Research Institute, Inc. | HILL, KEVIN KAI | 1638 | Final Rejection | May 18, 2022 |
| 17777011 | SILICA SHELL ENCAPSULATED POLYAROMATIC-CORE MICROPARTICLES | Arizona Board of Regents | SVEIVEN, MICHAEL CAMERON | 1678 | Non-Final OA | May 13, 2022 |
| 17735271 | COMPOSITIONS AND METHODS OF USING NMDAR INHIBITORS AND KINASE INHIBITORS TO TREAT LIVER CANCER | Centre For Oncology And Immunology Limited | MCANANY, JOHN D | 1625 | Final Rejection | May 03, 2022 |
| 17734826 | COMPOSITE FILAMENT FOR 3D PRINTING OF RESORBABLE BONE SCAFFOLDS | Arizona Board of Regents | BAHENA, CHRISTIE L. | 3774 | Final Rejection | May 02, 2022 |
| 17769642 | COMPOSITIONS AND METHODS FOR INHIBITION OF CELL-PENETRATING ANTIBODIES | Yale University | PATTERSON, SARAH COOPER | 1675 | Non-Final OA | Apr 15, 2022 |
| 17769524 | METHODS FOR MODULATING HUMAN L1 RETROTRANSPOSONS RNA AND COMPOSITIONS FOR USE THEREIN | Salk Institute For Biological Studies | KIM, TAEYOON | 1631 | Non-Final OA | Apr 15, 2022 |
| 17762931 | METHOD FOR ISOLATING EXTRACELLULAR VESICLES | Imperial College Innovations Limited | ZINGARELLI, SANDRA | 1653 | Non-Final OA | Mar 23, 2022 |
| 17694312 | TOPICAL DRUG DELIVERY DEVICES AND METHODS OF USE | Mjs Solutions, LLC | GHALI, ISIS A D | 1611 | Final Rejection | Mar 14, 2022 |
| 17641516 | NANOPARTICLES FOR SELECTIVE TISSUE OR CELLULAR UPTAKE | Yale University | LAZARO, DOMINIC | 1611 | Final Rejection | Mar 09, 2022 |
| 17640756 | COMPOSITIONS AND METHODS FOR COGNITIVE PROTECTION OF POLLINATORS AGAINST PESTICIDES | Pontificia Universidad Javeriana | GALSTER, SAMUEL LEONARD | 1693 | Non-Final OA | Mar 04, 2022 |
| 17677676 | TOPICAL NEUROSTEROID FORMULATIONS | Arizona Board of Regents | STEINKE, SEAN JAMES | 1619 | Non-Final OA | Feb 22, 2022 |
| 17669059 | THREE-DIMENSIONAL POROUS HYBRID SCAFFOLD AND MANUFACTURE THEREOF | Nanyang Technological University | MARTIN, PAUL C | 1653 | Non-Final OA | Feb 10, 2022 |
| 17584547 | CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATORY DOMAINS | H. Lee Moffitt Cancer Center and Research Institute, Inc. | SINGH, ANOOP KUMAR | 1632 | Non-Final OA | Jan 26, 2022 |
| 17583549 | Composition for and Method of Improving Tissue Performance | Ohio State Innovation Foundation | REYNOLDS, FRED H | 1658 | Non-Final OA | Jan 25, 2022 |
| 17628920 | COMBINATION THERAPY FOR TREATING RAS-MUTANT CANCERS | H. Lee Moffitt Cancer Center and Research Institute, Inc. | DARPOLOR, JOSEPHINE KEBBEH | 1642 | Non-Final OA | Jan 21, 2022 |
| 17625665 | COMPOSITIONS AND METHODS FOR CLEARING TISSUE | The University of Hong Kong | BARRON, SEAN C | 1653 | Non-Final OA | Jan 07, 2022 |
| 17622048 | NEURODEGENERATIVE DISEASE THERAPIES UTILIZING THE SKIN-BRAIN AXIS | Ohio State Innovation Foundation | HUDSON, AMY ROSE | 1636 | Non-Final OA | Dec 22, 2021 |
| 17557920 | ZERO-VALENT METAL AND BLACK CARBON FRAMEWORK AND METHOD OF USING SAME | MuniRem Environmental, LLC | MAYES, MELVIN C | 1759 | Non-Final OA | Dec 21, 2021 |
| 17616948 | COMPOSITIONS AND METHODS FOR MAKING HYBRID POLYPEPTIDES | Yale University | VANHORN, ABIGAIL LOUISE | 1636 | Final Rejection | Dec 06, 2021 |
| 17614934 | THERAPEUTIC B-CELLS ENGINEERED TO EXPRESS BISPECIFIC T CELL ENGAGER ANTIBODIES | H. Lee Moffitt Cancer Center and Research Institute, Inc. | SPENCE, JENNIFER SUZANNE | 1633 | Final Rejection | Nov 29, 2021 |
| 17526885 | METHODS RELATING TO PLURIPOTENT CELLS | VCell Therapeutics, Inc. | KIM, TAEYOON | 1631 | Non-Final OA | Nov 15, 2021 |
| 17610892 | SENSORS AND METHODS USING ELECTROCHEMILUMINESCENCE OF METAL NANOCLUSTERS | Georgia State University Research Foundation, Inc. | DICKINSON, PAUL W | 1618 | Non-Final OA | Nov 12, 2021 |
| 17517039 | PHARMACOKINETIC ENHANCEMENTS OF BIFUNCTIONAL CHELATES AND USES THEREOF | Centre For Probe Development And Commercialization | DONOHUE, SEAN R | 1618 | Non-Final OA | Nov 02, 2021 |
| 17296115 | DNA REFERENCE STANDARD AND USE THEREOF | Guangzhou Igene Biotechnology Co., Ltd. | GOLDBERG, JEANINE ANNE | 1682 | Final Rejection | Oct 29, 2021 |
| 17426057 | METHODS FOR PREDICTING A VERY LOW BIRTH WEIGHT | Imperial College Of Science, Technology And Medicine | GIAMMONA, FRANCESCA FILIPPA | 1681 | Non-Final OA | Jul 27, 2021 |
| 17416172 | PHOTOCLEAVABLE LINKER FOR CATCHING AND/OR RELEASING OF CIRCULATING TUMOR CELLS OR EXTRA CELLULAR VESICLES | The University of Kansas | VANHORN, ABIGAIL LOUISE | 1636 | Non-Final OA | Jun 18, 2021 |
| 17337357 | RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY | Fusion Pharmaceuticals Inc. | VU, JAKE MINH | 1618 | Final Rejection | Jun 02, 2021 |
| 17337358 | RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATION THERAPY | Fusion Pharmaceuticals Inc. | VALLE, ERNESTO | 1623 | Final Rejection | Jun 02, 2021 |
| 17294196 | ORAL WASH FOR ORAL FLUID COLLECTION AND ANALYSIS AND METHODS OF USE THEREOF | Decima Diagnostics, LLC | CRAIG, KAILA ANGELIQUE | 1618 | Final Rejection | May 14, 2021 |
| 17289590 | COMPOSITIONS AND METHODS FOR MODULATING EGG DEVELOPMENT IN MOSQUITOES | Arizona Board of Regents | DACE DENITO, ALEXANDRA GERALDINE | 1636 | Final Rejection | Apr 28, 2021 |
| 17286772 | ENGINEERED LONG INTERSPERSED ELEMENT (LINE) TRANSPOSONS AND METHODS OF USE | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | REGA, KYLE THOMAS | 1636 | Final Rejection | Apr 19, 2021 |
| 17284284 | EXTRACELLULAR VESICLES FOR TARGETED THERAPIES AGAINST MYELOID-DERIVED SUPPRESSOR CELLS | Ohio State Innovation Foundation | GUSTILO, ESTELLA M | 1646 | Non-Final OA | Apr 09, 2021 |
| 17281411 | TLR9-TARGETED THERAPEUTICS | Fulgent Pharma LLC | TRAN, CHRISTINA L | 1637 | Final Rejection | Mar 30, 2021 |
| 17278189 | IMPROVED HIGH-THROUGHPUT COMBINATORIAL GENETIC MODIFICATION SYSTEM AND OPTIMIZED CAS9 ENZYME VARIANTS | The University of Hong Kong | LIPPOLIS, ALEXANDRA ROSE | 1637 | Final Rejection | Mar 19, 2021 |
| 17272124 | COMPOSITIONS AND METHODS OF USING CELL-PENETRATING ANTIBODIES IN COMBINATION WITH IMMUNE CHECKPOINT MODULATORS | Yale University | ESSEX, LAURA ANN | 1675 | Final Rejection | Feb 26, 2021 |
| 17269968 | TREATMENT OF FLAVIVIRUS INFECTIONS IN HUMANS USING MUS MUSCULUS RESISTANT 2'-5' OLIGOADENYLATE SYNTHETASE 1B | Georgia Tech Research Corporation | DUNSTON, JENNIFER ANN | 1637 | Non-Final OA | Feb 19, 2021 |
| 17265756 | COMPOSITIONS AND METHODS FOR DETECTION AND IMAGING OF AMYLOID FIBRILS, AMYLOID PLAQUES, RNA, AND NUCLEOLI | The University of Hong Kong | NGUYEN, NAM P | 1678 | Non-Final OA | Feb 03, 2021 |
| 17259766 | COMPOSITIONS AND METHODS FOR REPROGRAMMING SKIN INTO INSULIN PRODUCING TISSUE | Ohio State Innovation Foundation | SINGH, ANOOP KUMAR | 1632 | Final Rejection | Jan 12, 2021 |
| 17054115 | COMPOSITIONS AND SYSTEMS FOR EX VIVO CELL MODULATION AND METHODS OF USE THEREOF | Yale University | TIWARI, VYOMA SHUBHAM | 1634 | Final Rejection | Nov 09, 2020 |
| 17048297 | IMMUNO-ONCOLYTIC MODIFIED VACCINIA TIAN TAN VIRUS AND METHODS OF TREATING CANCER | The University of Hong Kong | WANG, RUIXUE | 1672 | Final Rejection | Oct 16, 2020 |
| 17033050 | CELL-BASED CANCER VACCINES AND CANCER THERAPIES | Massachusetts Institute Of Technology | REDDIG, PETER J | 1646 | Non-Final OA | Sep 25, 2020 |
| 17011239 | VACCINE FOR TREATMENT OF CANCER AND METHOD OF MAKING BY STRESS REPROGRAMMING | VCell Therapeutics, Inc. | SULLIVAN, DENNIS JOHN | 1642 | Final Rejection | Sep 03, 2020 |
| 16985432 | CHIMERIC ANTIGEN RECEPTORS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS | The Trustees of Dartmouth College | ROGERS, ERIC JASON | 1638 | Final Rejection | Aug 05, 2020 |
| 16768319 | TRANSGENIC RICE PLANTS OVEREXPRESSING ACYL-COA-BINDING PROTEIN2 SHOW ENHANCED GRAIN SIZE | The University of Hong Kong | BOGGS, RUSSELL T | 1663 | Final Rejection | May 29, 2020 |
| 16619433 | RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATION THERAPY | Fusion Pharmaceuticals Inc. | CRAIGO, BAHAR ALAWI | 1699 | Non-Final OA | Dec 04, 2019 |
| 15661272 | ENZYMATIC PRE-TREATMENT OF MARKET PULP TO IMPROVE FIBER DRAINAGE AND PHYSICAL PROPERTIES | Exzymatic Deinking Technologies, LLC | CALANDRA, ANTHONY J | 1748 | Final Rejection | Jul 27, 2017 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial